(Q50634786)

17 March 2018

review article

1 reference

title

Osteoporosis in the corticosteroid-treated patient with asthma. (English)

1 reference

17 March 2018

0 references

0 references

1 reference

Ledford D

1

1 reference

17 March 2018

Apter A

2

1 reference

17 March 2018

Brenner AM

3

1 reference

17 March 2018

Rubin K

4

1 reference

17 March 2018

Prestwood K

5

1 reference

17 March 2018

Frieri M

6

1 reference

17 March 2018

Lukert B

7

1 reference

17 March 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

17 March 2018

The Journal of Allergy and Clinical Immunology

published in

1 reference

17 March 2018

volume

102

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

353-362

1 reference

17 March 2018

The osteoporosis revolution

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Epidemiology of vertebral fractures in women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Epidemiology of osteoporosis and osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

The crippling consequences of fractures and their impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Hip fractures in the elderly: a world-wide projection

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Hip fractures: a worldwide problem today and tomorrow

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Epidemiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Interaction of genetic and environmental influences on peak bone density

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Ethnic differences in hip fracture: a reduced incidence in Mexican Americans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone loss in response to long-term glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Clinical use of bone densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effect of calcium supplementation on bone loss in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Thiazide diuretic agents and the incidence of hip fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Testosterone therapy in glucocorticoid-treated men

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Influences on skeletal mineralization in children and adolescents: evidence for varying effects of sexual maturation and physical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone density in adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Growth of asthmatic children during treatment with alternate-day steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone mineral density in normal and asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of dose and dosing schedule of inhaled budesonide on bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Predictors of axial and peripheral bone mineral density in healthy children and adolescents, with special attention to the role of puberty

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Calcium supplementation and increases in bone mineral density in children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Mineral balance and bone turnover in adolescents with anorexia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Femoral neck and lumbar spine bone mineral densities in a normal population 3-20 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

Bone mineral density in adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970120-4

7 January 2021

10.1016/S0091-6749(98)70120-4

Identifiers

DOI

1 reference

17 March 2018

release_zbbci335uvgcvhmqqq245h54ky

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zbbci335uvgcvhmqqq245h54ky

24 November 2022

mapped directly with Wikidata item

1 reference

17 March 2018